<p>Rats were made neutropenic by injection of cyclophosphamide (CPA) on Day 0. Beginning on Day 1 and continuing through Day 5 different groups of rats received daily injections of G-CSF (100 μg/kg), G-CSF/IgG1-FcL (100 μg/kg) or vehicle solution. The No CPA control group did not receive CPA but did receive injections of vehicle solution on Days 1 through 5. Blood samples were obtained from the rats on the days indicated and neutrophil (<b>Panel A</b>) and white blood cell (<b>Panel B</b>) levels were measured. Data are means ± SE for 5 rats/group.</p
Rats were injected with either10 μg/kg of 833c and fresolimumab or 10μg 833c&Freso on day 2 after bl...
The systemic administration of granulocyte-macrophage colony-stimulating factor (GMCSF) is used clin...
It was shown that long-term (7 and 21 day) administration of CdCl2 (3 mg/kg) increases the number of...
<p>Rats were made neutropenic by injection of CPA on Day 0. On Day 1 different groups of rats receiv...
Abstract: Neutrophil function was examined in rats treated with recombinant human granulocyte colony...
<p>Compared to vehicle treatment in rats with CCI, G-CSF treatment in rats with CCI significant incr...
<p>Mice received a subcutaneous injection every day for 5 days with vehicle solution, or the indicat...
<p>Mice received subcutaneous injections every day (ED; on Days 1–5) or every other day (EOD; on Day...
<p>Mice received subcutaneous injections every day (ED; on Days 1–5) or every third day (ETD; on Day...
Granulocyte-colony stimulating factor is a glycoprotein that stimulates synthesis of granulocytes, e...
Myelosuppression during intensive chemotherapy frequently is a reason of therapy disruption and risi...
The definitive version may be found at www.wiley.comBackgroundPatients with severe chronic and cycli...
<p>Leukocyte (<b>A</b>), neutrophil (<b>B</b>), and platelet (<b>C</b>) cell blood counts at day 5 a...
Previously we showed that granulocyte colony-stimulating factor (G-CSF) in vitro bioactivity is pres...
BackgroundTowards gene therapy treatment of patients with neutropenia, characterized by neutrophil c...
Rats were injected with either10 μg/kg of 833c and fresolimumab or 10μg 833c&Freso on day 2 after bl...
The systemic administration of granulocyte-macrophage colony-stimulating factor (GMCSF) is used clin...
It was shown that long-term (7 and 21 day) administration of CdCl2 (3 mg/kg) increases the number of...
<p>Rats were made neutropenic by injection of CPA on Day 0. On Day 1 different groups of rats receiv...
Abstract: Neutrophil function was examined in rats treated with recombinant human granulocyte colony...
<p>Compared to vehicle treatment in rats with CCI, G-CSF treatment in rats with CCI significant incr...
<p>Mice received a subcutaneous injection every day for 5 days with vehicle solution, or the indicat...
<p>Mice received subcutaneous injections every day (ED; on Days 1–5) or every other day (EOD; on Day...
<p>Mice received subcutaneous injections every day (ED; on Days 1–5) or every third day (ETD; on Day...
Granulocyte-colony stimulating factor is a glycoprotein that stimulates synthesis of granulocytes, e...
Myelosuppression during intensive chemotherapy frequently is a reason of therapy disruption and risi...
The definitive version may be found at www.wiley.comBackgroundPatients with severe chronic and cycli...
<p>Leukocyte (<b>A</b>), neutrophil (<b>B</b>), and platelet (<b>C</b>) cell blood counts at day 5 a...
Previously we showed that granulocyte colony-stimulating factor (G-CSF) in vitro bioactivity is pres...
BackgroundTowards gene therapy treatment of patients with neutropenia, characterized by neutrophil c...
Rats were injected with either10 μg/kg of 833c and fresolimumab or 10μg 833c&Freso on day 2 after bl...
The systemic administration of granulocyte-macrophage colony-stimulating factor (GMCSF) is used clin...
It was shown that long-term (7 and 21 day) administration of CdCl2 (3 mg/kg) increases the number of...